CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Apr. 30, 2024	Apr. 30, 2023	Apr. 30, 2024	Apr. 30, 2023
Operating expenses:
Research and development	$ 9,855	$ 3,215	$ 15,493	$ 6,886
General and administrative	7,455	1,522	12,590	2,484
Total operating expenses	17,310	4,737	28,083	9,370
Loss from operations	17,310	4,737	28,083	9,370
Other (income) expense, net:
Change in fair value of convertible debentures embedded derivative liabilities		(625)		(318)
Change in fair value of warrant liabilities		341		1,526
Interest income	(2,984)	(149)	(4,009)	(316)
Interest Expense	728	1,177	1,291	2,352
Loss on extinguishment of debt			366
Other expense, net	(91)	(199)	(27)	86
Total other (income) expense, net	(2,347)	545	(2,379)	3,330
Net loss before provision for income taxes	14,963	5,282	25,704	12,700
Provision for (benefit from) income taxes	21	0	(9)	0
Net loss and comprehensive loss	14,984	5,282	25,695	12,700
Deemed dividend attributable to redeemable convertibleb preferred shareholders		1,175		2,389
Net loss attributable to common shareholders, basic	14,984	6,457	25,695	15,089
Net loss attributable to common shareholders, diluted	$ 14,984	$ 6,457	$ 25,695	$ 15,089
Net loss per share of common shares, basic	$ 0.38	$ 9.3	$ 0.82	$ 22.19
Net loss per share of common shares, diluted	$ 0.38	$ 9.3	$ 0.82	$ 22.19
Weighted-average common shares outstanding, basic	39,443,768	694,497	31,186,238	680,003
Weighted-average common shares outstanding, diluted	39,443,768	694,497	31,186,238	680,003